Pfizer has reached a turning point.
Jan 20 (Reuters) - Novavax ‌said on Tuesday it signed a licensing ‌agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, ...
Pfizer's Chief Talent Officer explains how the "pilot in command" framework scaled from nine teams to 700, and why Workday made it real.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results